Company page

Climb Bio, Inc.

Climb Bio, Inc. (ticker: CLYM) is a public company based in America with a market capitalization of approximately $735.26 million. The company focuses on biotechnology and aims to develop innovative solutions in its field. Climb Bio is committed to advancing its research and development efforts to contribute to the healthcare industry.